Teaming Up to Increase HPV Immunization Rates: Rapid Response from SAHM 2018 Annual Meeting

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various types of cancer. An estimated 79 million people in the United States are infected with some type of HPV, and approximately 50% of new infections occur in individuals before the age of 24. Despite the availability of safe and effective vaccines, HPV vaccination coverage remains low. There are various reasons why the vaccination rates are low, including patients’ and/or parents' lack of knowledge about HPV and their discomfort with talking to health care providers about sexual activity. This roundtable discussion among leading experts of HPV, exploring the latest clinical advances and recent data regarding HPV vaccination, was recorded during the 2018 Society for Adolescent Health and Medicine (SAHM) meeting in Seattle, Washington. These experts will also discuss the current challenges and controversies around HPV vaccination, including communication tactics and strategies to overcome these obstacles. 
Learning Objectives: 
  • Review the latest clinical data regarding the impact of HPV vaccination on relevant clinical endpoints.
  • Assess new strategies to educate and empower adolescents to become engaged in their own health as it relates to HPV vaccination.
  • Evaluate the value of concise and consistent communication to educate patients/caregivers on the importance of competing the HPV vaccination series.

Activity Chair:
Gregory D. Zimet, PhD, FSAHM
Professor of Pediatrics & Clinical Psychology
Co-Director, Indiana University, Purdue University Indianapolis Center for HPV Research
Division of Adolescent Medicine, Department of Pediatrics
Indiana University School of Medicine
Indianapolis, IN
Amy B. Middleman, MD, MSEd, MPH
Professor of Pediatrics
Chief, Section of Adolescent Medicine
University of Oklahoma
Health Sciences Center
Oklahoma City, OK 
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
This enduring material is approved for 1 year from the date of release, March 29, 2018 through March 28, 2019.